Francis Wright, M.D. appointed as Chair of Chronic Kidney Disease Task Force

Translate to Spanish or other 102 languages!

Governor Greg Abbott named Francis Wright, M.D. as Chair of the Chronic Kidney Disease Task Force for a term at the pleasure of the Governor. Image source:  texaskidney.org
Governor Greg Abbott named Francis Wright, M.D. as Chair of the Chronic Kidney Disease Task Force for a term at the pleasure of the Governor. Image source:  texaskidney.org

Mega Doctor News

- Advertisement -

AUSTIN, Texas – Governor Greg Abbott named Francis Wright, M.D. as Chair of the Chronic Kidney Disease Task Force for a term at the pleasure of the Governor. The task force coordinates implementation of the state’s plan for prevention, early screening, diagnosis, and management of chronic kidney disease and educates health care professionals.

Francis Wright, M.D. of San Antonio is the Medical Director for Transplant Care Consultants and previously served as Surgical Director and Transplant Surgeon at the Methodist Specialty and Transplant Hospital in San Antonio since 1994. He did an organ transplant fellowship at the University of Iowa Hospitals in 1988 where he was on the surgery faculty. He was the founding director of the kidney and pancreas transplant programs at Centennial Medical Center in Nashville prior to returning to San Antonio. He is certified by the American Board of Surgery and is a Fellow of the American College of Surgeons. He is a member of the American Society of Transplant Surgeons, Texas Transplant Society, American Transplantation Society, and the International Transplantation Society. He has served on boards and committees for the State of Texas Kidney Foundation, the American Foundation for Donation and Transplantation, the US Renal Network 14, and the United Network for Organ Sharing. Wright received a Doctor of Medicine degree from The University of Texas Health Science Center at San Antonio.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 
- Advertisement -